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Abstract
Background: Studies on asbestos-induced tumourigenesis have indicated the role of, e.g., reactive oxygen/nitrogen species,
mitochondria, as well as NF-κB and MAPK signalling pathways. The exact molecular mechanisms contributing to asbestos-
mediated carcinogenesis are, however, still to be characterized.
Methods: In this study, gene expression data analyses together with gene annotation data from the Gene Ontology (GO)
database were utilized to identify pathways that are differentially regulated in lung and tumour tissues between asbestos-exposed
and non-exposed lung cancer patients. Differentially regulated pathways were identified from gene expression data from 14
asbestos-exposed and 14 non-exposed lung cancer patients using custom-made software and Iterative Group Analysis (iGA).
Western blotting was used to further characterize the findings, specifically to determine the protein levels of UBA1 and UBA7.
Results: Differences between asbestos-related and non-related lung tumours were detected in pathways associated with, e.g.,
ion transport, NF-κB signalling, DNA repair, as well as spliceosome and nucleosome complexes. A notable fraction of the
pathways down-regulated in both normal and tumour tissue of the asbestos-exposed patients were related to protein
ubiquitination, a versatile process regulating, for instance, DNA repair, cell cycle, and apoptosis, and thus being also a significant
contributor of carcinogenesis. Even though UBA1 or UBA7, the early enzymes involved in protein ubiquitination and ubiquitin-
like regulation of target proteins, did not underlie the exposure-related deregulation of ubiquitination, a difference was detected
in the UBA1 and UBA7 levels between squamous cell carcinomas and respective normal lung tissue (p = 0.02 and p = 0.01)
without regard to exposure status.
Conclusion: Our results indicate alterations in protein ubiquitination related both to cancer type and asbestos. We present
for the first time pathway analysis results on asbestos-associated lung cancer, providing important insight into the most relevant
targets for future research.
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Background
Asbestos is a natural mineral fibre with physical and
chemical properties that have led to its widespread use for
various insulation and construction purposes. Asbestos-
exposure is associated with malignancies of the lung and
pleura, and tobacco smoking and asbestos-exposure are
known to have a synergistic effect on lung cancer risk [1].
Although the use of asbestos is nowadays forbidden or
under strict control in most developed countries, asbes-
tos-associated malignancies continue to be a major health
problem worldwide due to the long latency period and
the extensive usage in the past.
Asbestos fibre characteristics such as length and chemical
properties contribute to their toxicity. As macrophages
attempt to engulf the fibres, reactive oxygen and nitrogen
species (ROS/RNS) are produced. The iron content of
asbestos further contributes to the production of these
potentially damaging species. ROS/RNS account for sev-
eral types of DNA and chromosomal damage including
formation of mutagenic 8-OHdG adducts and DNA dou-
ble strand breaks, as well as alterations in signal transduc-
tion pathways and apoptosis [2-4].
A major part of the research on asbestos-carcinogenesis is
based on animal and in vitro models. These studies,
including ours on human cell lines exposed to asbestos
[5], have indicated numerous changes in several key path-
ways. The most studied signalling cascades induced by
asbestos include the MAPK/ERK and NF-κB pathways
[6,7]. Activation of the MAPK cascade affects processes
such as cell proliferation, apoptosis, differentiation, and
inflammation [7,8]. The apoptotic pathways can be fur-
ther distorted by alterations in the normal mitochondrial
functions, such as induction of cytochrome C release and
caspase 9 activation, following asbestos-exposure [9].
Asbestos fibres may also directly interact with the cell
cycle machinery that could affect normal cell division
[10]. In spite of these observations a comprehensive view
on the carcinogenic effects of asbestos fibres still remains
largely unknown.
We have recently shown that specific gene copy number
and gene expression changes can be detected in lung
tumours of asbestos-exposed patients [11,12]. Although
several differentially expressed genes were revealed, the
single gene approaches that were applied were not suita-
ble for identification of deregulated pathways. To gain fur-
ther insight into the pathways that are differentially
regulated in lung tumours of asbestos-exposed and non-
exposed patients we have now performed in silico pathway
analysis. Differences were sought both in the normal and
tumour tissue. While a single gene might not show a sig-
nificant difference according to asbestos-exposure, mod-
erate differences in a number of genes operating in the
same pathway could indicate differential regulation of the
whole pathway. Therefore, this approach has the potential
of producing a wider mechanistic view on the asbestos-
related effects.
We observed several down-regulated pathways that were
related to protein ubiquitination in both normal and
tumour tissues, whereas the GO terms related to ion trans-
port dominated among the up-regulated pathways. Pro-
tein ubiquitination was chosen for further investigation
owing to its pivotal role in controlling the replicative
potential of a cell. Ubiquitin-activating enzyme E1
(UBA1) and ubiquitin-activating enzyme E1-like (UBA7)
were analyzed further due to their roles at the early stages
of protein ubiquitination and ubiquitin-like modification
processes. To our knowledge, this is the first time when
primary tissue samples from asbestos-exposed and non-
exposed lung cancer patients have been utilized to per-
form a comprehensive pathway analysis.
Methods
Lung cancer patients
Normal and tumour lung tissue samples were obtained
from 14 heavily asbestos-exposed and 14 non-exposed
Finnish lung cancer patients as described in Nymark et al.
[11]. The patients were interviewed for the occupational
and tobacco smoking history and their informed consent
to participate in the study was obtained. A patient was
classified as heavily asbestos-exposed based on employ-
ment history and lung tissue asbestos fibre count of more
than 5 million fibres per gram of dry lung tissue [13]. The
asbestos-exposed and non-exposed patient groups were fit
to match the following features: sex (all male), smoking
status (current or ex-smokers with similar smoking his-
tory), as well as grade, stage and histological type of the
tumour. The study protocols were approved by the Ethical
Review Board for Research in Occupational Health and
Safety, Helsinki and Uusimaa Hospital District (75/E2/
2001).
Gene expression and pathway analysis
Gene expression analyses on normal and tumour tissue
samples from the 28 lung cancer patients were performed
using Affymetrix HG-U133A GeneChips (Affymetrix,
Santa Clara, CA, USA) as previously described [12]. After
scanning the chips the gene expression data were preproc-
essed using the GC Robust Multi-array average method
[14]. The Gene Ontology (GO) Database [15,16] was
searched for pathway (GO term) information for the
genes represented on the chip. Annotations to biological
processes, molecular functions, and cellular localization
were utilized in the analyses. Custom-made software and
Iterative Group Analysis (iGA) [17] were used to obtain
information on the differentially regulated pathways.BMC Medical Genomics 2008, 1:55 http://www.biomedcentral.com/1755-8794/1/55
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First, the genes were rank ordered with respect to differ-
ences in gene expression between the two groups of
patients. Both p-values from the t-test and the fold-change
between the medians of the two groups were used in per-
forming the ranking, thus two rank lists were obtained.
Comparisons between the groups were performed on nor-
mal tissue vs. normal tissue and tumour vs. tumour, sepa-
rately for both up- and down-regulated pathways. iGA was
then applied to test the categories defined by GO for
enrichment of over or under expressed genes, separately
for the t-test and fold-change based rank lists. This
approach was chosen due to the complexity of carcino-
genic processes in the lung. The complexity makes the
identification of the most important differences between
the tumour and normal tissues of the asbestos-exposed
using genome-wide gene expression difficult. Owing to
this inherent difficulty we chose to compare tumour vs.
tumour and normal vs. normal and integrate the results to
decipher changes specifically caused by exposure to asbes-
tos.
iGA was applied on the ranked lists to test each pathway
for enrichment of differentially expressed genes. The
method does not require defining of thresholds for differ-
ential expression but instead determines an optimal p-
value for each pathway by considering all possible
options for the number of over- or under-expressed genes.
The final permuted p-values were obtained by means of
hypothesis testing using 50,000 permutations of the
group labels.
Western blot
To determine the protein expression levels of UBA1 and
UBA7, we performed Western blotting on fresh frozen
tumour and respective normal lung tissue from asbestos-
exposed and non-exposed lung cancer patients. A total of
six asbestos-exposed and six non-exposed cases were
included in the analyses with both groups containing
three adenocarcinomas (ACs) and three squamous cell
carcinomas (SCCs). Cytoplasmic and nuclear proteins
were extracted from fresh frozen tissue samples using NE-
PER extraction kit according to the protocol provided
(Pierce, Rockford, IL). The percentage of tumour tissue on
frozen sections from the same samples was evaluated by a
pathologist before protein extraction and was typically
around 50%. Protein concentration was measured using
DC protein assay (Bio-Rad, Hercules, CA) and equal
amounts of proteins of the cytoplasmic fraction were
loaded onto 10–20% Criterion Tris-HCl gels (Bio-Rad).
Proteins were blotted onto Immobilon-P PVDF mem-
brane (Millipore, Billerica, MA, USA). UBA1 and UBA7
detections were performed using the following antibod-
ies: rabbit polyclonal antibodies to UBA1 (ab16849) and
UBA7 (ab12199) (Abcam, Cambridge, UK) at 1:5000 and
1:2000 dilutions, respectively. Rabbit polyclonal anti-
body to GAPDH (ab9485, Abcam) at a 1:2000 dilution
was utilized as an internal control. Biotinylated anti-rab-
bit IgG (Vector Laboratories Inc., Burlingame, CA, USA) at
a 1:15000 dilution together with streptavidin-horseradish
peroxidase conjugate (Amersham Biosciences, NJ, USA) at
a 1:5000 dilution were applied. The signal was detected by
using an ECL reagent (Amersham Biosciences), and the
UBA1, UBA7, and GAPDH band intensities were quanti-
fied with an ImageMaster program (Amersham Bio-
sciences).
Results
Asbestos-related pathways
When GO terms from all levels of specificity were consid-
ered, several differentially regulated pathways (GO terms)
were identified both in normal and tumour tissue of
asbestos-exposed patients as compared to the non-
exposed (Additional files 1 and 2). The detection of a large
number of potentially affected pathways was expected
owing to the presence of thousands of GO terms, all of
which were tested for differences between the two groups.
The findings implicated alterations in many vital aspects
of cell homeostasis (Figure 1). The pathway analysis
revealed some previously presented asbestos-associated
molecular alterations, such as deregulation of NF-κB path-
way that was observed in the normal tissue samples from
asbestos-exposed patients. Additional somewhat expected
findings included changes in DNA repair and mitochon-
drial functions.
The GO terms share a parent-child relationship in which
the children are detailed descriptions of the parents.
Hence, the terms can be organized into a treelike structure
where each branch contains related cellular functions,
processes or locations. To pinpoint perhaps the most rel-
evant findings in our data we sought for those branches
that contained at least three GO terms with permuted p-
values < 0.05 obtained using both t-test and fold change
based ranking. Furthermore, we were interested in identi-
fying categories from which targets for additional analyses
could be selected and thus considered only branches with
significant results on categories containing less than 100
genes. Consequently, we identified 30 down-regulated
and 40 up-regulated pathways in the normal tissue, and
22 down-regulated and 37 up-regulated pathways in the
tumour tissue (data not shown). 27 up-regulated and 8
down-regulated pathways detected in the tumour were in
common with those in the normal tissue (Additional file
3). Figures 2 and 3 shows the differentially regulated bio-
logical processes from all levels of specificity related to
one of the up-regulated and one of the down-regulated
processes, ion transport and protein ubiquitination,
respectively.BMC Medical Genomics 2008, 1:55 http://www.biomedcentral.com/1755-8794/1/55
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Among the most intriguing findings were the up-regulated
pathways associated with ion transport and the down-reg-
ulated pathways associated with protein ubiquitination
both in the normal and tumour tissues. Six out of 24 bio-
logical processes and molecular functions up-regulated in
both normal and tumour tissues of the exposed patients
were ion transport related, whereas three out of the eight
down-regulated terms were related to ubiquitination (see
Additional file 3). Interestingly, our previous investiga-
tions of time-dependent gene expression changes of three
cell lines (A549, BEAS 2B and Met5A) also indicated mod-
ifications in protein ubiquitination and ion transport after
exposure to crocidolite asbestos fibres [5]. In that study,
we performed similar pathway analysis as in the current
work and found deregulation of ubiquitination related
GO terms in all three cell lines 24 h or 48 h after the expo-
sure [5]. Coinciding findings from patient samples and in
vitro models could imply importance of ubiquitination in
asbestos-related lung carcinogenesis.
UBA1 and UBA7 in lung tumours and normal lung
To assess the potential importance of UBA1 and/or UBA7
in asbestos-associated lung cancer or lung carcinomas in
general we measured the protein levels in normal and
tumour tissue samples of 12 lung cancer patients (data
not shown). Both exposed and non-exposed study groups
contained three ACs and three SCCs and the correspond-
ing normal tissue samples.
The GAPDH-scaled protein expression levels of UBA1 and
UBA7 were compared between the exposed and non-
exposed lung cancer patients, separately for the normal
and tumour tissue samples. The expression levels were
also compared between the normal and tumour samples,
separately for AC and SCC cases, irrespective of the expo-
sure status of the patients. We did not detect exposure-
related differences in UBA1 or UBA7 levels in the normal
or tumour tissue samples. In the SCC group, however,
protein expression of both UBA1 and UBA7 were signifi-
cantly lower in tumour than in the normal tissue, p = 0.02
and p = 0.01 (two-sided t-test), respectively. The results
are summarized in Table 1. The gene expression microar-
ray data also showed that UBA1 and UBA7 mRNA levels
were significantly lower in the SCCs compared to the
respective normal tissue samples (Table 1).
Presentation of asbestos-induced effects Figure 1
Presentation of asbestos-induced effects. Schematic presentation of asbestos-induced effects, modified from Upadhyay 
and Kamp [38]. Mechanisms or cellular compartments affected by asbestos-exposure according to the pathway analysis are 
marked with black dots.
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Discussion
Here we have presented, for the first time, comprehensive
pathway analysis on asbestos-related lung cancer. Fresh
frozen tissue samples were analyzed from well-defined
patient material consisting of asbestos-exposed and non-
exposed lung cancer patients. Gene expression measure-
ments together with gene annotation data from the Gene
Ontology database were utilized to identify potential
asbestos-associated pathways.
The pathway analysis provides an attractive means for
detecting gene expression changes that have occurred in a
number of genes involved in the same biological proc-
esses or molecular functions, or located in the same cellu-
lar compartment. At the gene level, the changes in
expression do not have to be significant, opposed to the
single gene approaches that are commonly used to ana-
lyze high-throughput data. Moreover, as the samples in
both the exposed and non-exposed groups represented
different tumour types, the analysis was insensitive to the
differences between the histological tumour types.
We observed a multitude of differences between the asbes-
tos-associated and non-associated lung cancer in several
key cellular events. In order to pinpoint the truly mean-
ingful molecular changes and to reduce the chance of false
findings resulting from the large number of statistical tests
that are being made the significance thresholds should be
stringent enough. To pinpoint the most relevant findings
in our data, we performed a two-step analysis, where the
significance of each category was first assessed by enrich-
ment of differentially expressed genes in the category. The
Protein ubiquitination related differentially regulated processes Figure 2
Protein ubiquitination related differentially regulated processes. The dotted boxes represent GO terms that were 
down-regulated in both the normal and the tumour tissues of the exposed patients in comparison to the non-exposed using 
both the t-test and fold change based ranking. The grey boxes represent GO terms that were down-regulated using at least 
one of the tests.
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GO:0016567 Protein ubiquitination BMC Medical Genomics 2008, 1:55 http://www.biomedcentral.com/1755-8794/1/55
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significance of the categories was evaluated by means of
hypothesis testing using 50,000 permutations of the
group labels. Both p-values from the t-test and fold-
change between the group medians were used as measures
of differential expression. Thereafter, we required that at
least three components of a GO branch had to be signifi-
cant according to the two measures. In addition to the
challenges related to performing multiple statistical tests,
it is noteworthy that the pathway analysis is based on the
current knowledge of gene functions and processes occur-
ring in the cellular environment, which has been derived
using versatile methods. Therefore, future findings may
Ion transport related differentially regulated processes Figure 3
Ion transport related differentially regulated processes. The dotted boxes represent GO terms that were up-regulated 
in both the normal and the tumour tissues of the exposed patients in comparison to the non-exposed using both the t-test and 
fold change based ranking. The grey boxes represent GO terms that were up-regulated using at least one of the tests.
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localization
GO:0006811 Ion transport
GO:0006812 Cation transport
GO:0030001 Metal ion transport
GO:0006814 Sodium ion 
transport
GO:0006810 Transport
GO:0008150 Biological process
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inorganic cation transport
GO:0006813 Potassium ion
transport
GO:0015674 Di-, tri-valent
inorganic ion transport
GO:0015690 Aluminum ion 
transport
Table 1: The protein expression levels of UBA1 and UBA7 in the tumour and normal tissue of adenocarcinoma and squamous cell 
carcinoma patients obtained using Western analysis and gene expression (GE) microarrays
UBA1 UBA7
Western GE probe 1 Western GE probe 1 GE probe 2
Tissue typea Median
[range]
Median
[range]
SCC 0.72
[0.29 0.91]
1097
[827 1410]
0.16
[0.13 0.27]
71
[54 88]
84
[67 95]
Normal 1.3
[0.81 2.8]
1723
[1037 1815]
0.74
[0.50 1.7]
131
[108 170]
194
[147 253]
p-valueb 0.02 0.03 0.01 0.00086 0.00018
AC 1.1
[0.70 1.2]
1326
[658 1656]
0.50
[0.15 0.62]
104
[72 160]
122
[68 228]
Normal 1.1
[0.24 1.9]
1162
[932 1601]
0.46
[0.11 0.95]
137
[119 221]
203
[162 406]
p-valueb 0.80 0.42 0.79 0.01 0.003
aAC, adenocarcinoma; SCC, squamous cell carcinoma
bp-value was calculated using two-sided t-testBMC Medical Genomics 2008, 1:55 http://www.biomedcentral.com/1755-8794/1/55
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unravel further differences between the asbestos-exposed
and non-exposed or provide deeper insight into the differ-
ences between these two groups.
Some of the characteristics observed in the asbestos-
exposed group have already been presented in the litera-
ture, indicating the utility of this approach. Interestingly,
ion channel related GO terms dominated the list of up-
regulated pathways. Asbestos could be linked to up-regu-
lation of ion channels through ROS, which has been
shown to trigger the opening of mitochondrial channels
and mitochondrial depolarization [18]. Ion channel
defects have been observed to underlie various diseases
[19-21], but also suggested to have a significant role in
tumourigenesis and tumour progression [[22], reviewed
in [23]]. Ion channels could be an important target for fur-
ther studies, also in relation to asbestos, because they con-
tribute to virtually all basic cellular processes such as
proliferation, differentiation, and apoptosis [[24],
reviewed in [25]].
Among the down-regulated pathways, biological proc-
esses and molecular functions related to protein ubiquiti-
nation, a versatile process regulating various key cellular
events such as DNA repair, cell cycle, and apoptosis [26],
were the most intriguing findings. Furthermore, many of
the other significantly altered pathways identified here are
connected to ubiquitin-mediated cellular trafficking and
degradation by the proteasome. These include, e.g., clath-
rin-coated vesicles and modification-dependent protein
catabolism as well as pathways implicated in transport
between Golgi and endoplasmic reticulum. Also, asbestos
could have a direct interaction with cellular constituents
[7] such as the nucleosome and spliceosome complexes.
Of note, deregulated ubiquitination has been linked to
carcinogenesis [27], especially to mesothelioma [[28,29]
(unpublished data)], a disease tightly linked to asbestos-
exposure.
We chose protein ubiquitination as a target for further
analysis due to its versatile role in many aspects of cellular
homeostasis and, e.g., the replicative potential of a cell
and as it therefore may in fact underlie several of the pre-
viously presented molecular alterations in asbestos-asso-
ciated carcinogenesis. Due to limited availability of ample
fresh frozen samples we chose two targets for further
research. Namely, the protein levels of UBA1 and UBA7 in
the tumour and respective normal tissue of asbestos-
exposed and non-exposed patients were analyzed due to
their role at the early stages of protein ubiquitination and
ubiquitin-like modification processes. UBA1, an E1
enzyme, initiates the addition of ubiquitin signalling tags
to target proteins. E1 enzyme transfers ubiquitin to E2
enzyme, which together with E3 enzyme subsequently
tags the substrate [26]. Proteins involved in ubiquitin-like
modification processes, such as UBA7, seem also to play a
role in the ubiquitin-proteasome system [30,31]. UBA7
strikes as an interesting candidate also because of the low
expression levels detected in lung cancer cell lines and the
location of the gene on 3p21, a region frequently deleted
in lung carcinomas associated with tobacco smoking and
asbestos-exposure [11,32,33].
According to our analysis of a rather small number of nor-
mal and tumour tissue samples the asbestos-related dereg-
ulation of ubiquitination seems neither to be caused by
UBA1 nor UBA7. However, several other enzymes are also
involved in protein ubiquitination besides UBA1 and
UBA7. To identify the asbestos-associated alterations of
the pathway, more holistic approaches analyzing a multi-
tude of associated proteins in a large number of samples
could be useful. Mass spectrometry analyses or immuno-
histochemistry performed on tissue arrays, applied on
normal and tumour tissues of asbestos-exposed and non-
exposed lung cancer patients, might reinforce the data
presented here. Furthermore, imaging techniques on cell
lines could provide additional information on the possi-
ble deregulations in ubiquitination.
We observed under-expression of UBA1 and UBA7 in
SCCs, but not in ACs, both at the mRNA and protein level.
This finding appears to contradict some studies, which
have suggested a higher risk of AC than SCC in association
with asbestos-exposure [34]. Several epidemiological
studies on asbestos-related cancer have shown, however,
similar risk ratios for all major histological types of lung
cancer [35-37]. The results thus indicate both asbestos
and cancer type specific alterations in protein ubiquitina-
tion with different components of ubiquitination path-
way potentially contributing to different types of lung
cancer. Future work is needed to understand the altera-
tions connected with asbestos and histological cancer
types
Conclusion
The pathway analysis depicts a thorough picture of the
molecular changes induced by asbestos-exposure and
indicates that there are distinct differences between asbes-
tos-related and non-related lung tumourigenesis. Specifi-
cally, up-regulation of the pathways associated with ion
transport and down-regulation of the functions related to
protein ubiquitination were found in the normal and
tumour tissue of exposed patients. The data will provide
the research community important insight into the rele-
vant targets underlying asbestos-associated lung cancer.
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